Mannkind (MNKD) Total Debt (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.22% |
| Dec 31, 2025 | 23.52% |
| Sep 30, 2025 | -19.26% |
| Jun 30, 2025 | -0.06% |
| Mar 31, 2025 | -0.17% |
| Dec 31, 2024 | -0.06% |
| Sep 30, 2024 | 0.00% |
| Dec 31, 2023 | 1,079.17% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 242.93% |
| Sep 30, 2020 | -30.00% |
| Jun 30, 2019 | -2.96% |
| Mar 31, 2019 | 0.04% |
| Dec 31, 2018 | -3.43% |
| Sep 30, 2018 | -21.65% |
| Jun 30, 2018 | -4.92% |
| Mar 31, 2018 | -12.47% |
| Dec 31, 2017 | -3.78% |
| Sep 30, 2017 | 0.33% |
| Jun 30, 2017 | 13.05% |
| Mar 31, 2017 | 0.38% |
| Dec 31, 2016 | 0.37% |
| Sep 30, 2016 | -3.65% |
| Jun 30, 2016 | 0.35% |
| Mar 31, 2016 | 0.34% |
| Dec 31, 2015 | 0.34% |
| Sep 30, 2015 | 0.33% |
| Jun 30, 2015 | 0.32% |
| Mar 31, 2015 | 0.30% |
| Dec 31, 2014 | 49.73% |
| Sep 30, 2014 | -6.23% |
| Jun 30, 2014 | 76.22% |
| Mar 31, 2014 | -58.97% |
| Dec 31, 2013 | 0.89% |
| Dec 31, 2012 | -46.39% |
| Sep 30, 2012 | 2.29% |
| Jun 30, 2012 | -23.04% |
| Mar 31, 2012 | 2.25% |
| Dec 31, 2011 | 0.00% |
| Sep 30, 2011 | 14.45% |